Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Randomized, controlled study of the impact of a mobile health tool on asthma SABA use, control and adherence

David Van Sickle, Meredith Barrett, Olivier Humblet, Kelly Henderson, Chris Hogg
European Respiratory Journal 2016 48: PA1018; DOI: 10.1183/13993003.congress-2016.PA1018
David Van Sickle
1Research & Development, Propeller Health, Madison, WIUnited States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meredith Barrett
1Research & Development, Propeller Health, Madison, WIUnited States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olivier Humblet
1Research & Development, Propeller Health, Madison, WIUnited States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kelly Henderson
1Research & Development, Propeller Health, Madison, WIUnited States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chris Hogg
2Research & Development, Propeller Health, San Francisco, CAUnited States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Background Mobile health technology has demonstrated impacts on improving asthma outcomes, but few studies have evaluated outcomes in a controlled study in a real-world clinical setting.

Aims and Objectives We aimed to determine whether a sensor-enabled, clinically-integrated mobile health asthma quality improvement program could reduce the frequency of short-acting beta agonist (SABA) use, and increase asthma-free days, asthma control and controller medication adherence.

Methods Adult patients with asthma and a SABA prescription were enrolled (n=125). Participants randomized to the intervention group (IG) (n=67) received electronic inhaler sensors to track their medication use, and access to smartphone and online applications that provided visualizations of their data, reminders to promote adherence, and personalized, guidelines-based education. Clinical care managers viewed IG patients' data in an online dashboard to guide care. Participants in the control group (CG) (n=58) received sensors, but neither the patient nor the care manager received access to their data. Mixed effects regression models with random intercepts were used to compare outcomes between groups at 6 months.

Results The IG demonstrated significant improvements compared to the CG on all clinical outcomes, including controller medication adherence, daily SABA use, asthma-free days, and asthma control (all p<0.001), including a 21-point improvement in adherence for the IG.

Conclusions This mobile health program, with sensor-enabled data collection and patient and provider access to the data, improved asthma outcomes, including asthma SABA use, control, and adherence in a real-world clinical setting.

  • Asthma - management
  • E-health
  • Telemedicine
  • Copyright ©the authors 2016
Previous
Back to top
Vol 48 Issue suppl 60 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Randomized, controlled study of the impact of a mobile health tool on asthma SABA use, control and adherence
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Randomized, controlled study of the impact of a mobile health tool on asthma SABA use, control and adherence
David Van Sickle, Meredith Barrett, Olivier Humblet, Kelly Henderson, Chris Hogg
European Respiratory Journal Sep 2016, 48 (suppl 60) PA1018; DOI: 10.1183/13993003.congress-2016.PA1018

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Randomized, controlled study of the impact of a mobile health tool on asthma SABA use, control and adherence
David Van Sickle, Meredith Barrett, Olivier Humblet, Kelly Henderson, Chris Hogg
European Respiratory Journal Sep 2016, 48 (suppl 60) PA1018; DOI: 10.1183/13993003.congress-2016.PA1018
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Respiratory outcomes in young adults following extremely preterm birth
  • X-Tab: Non-interventional study to assess patient-related mid-term outcomes of omalizumab therapy in severe allergic asthmatic patients
  • Prevalence of refractory asthma in population with severe asthma
Show more 5.2 Monitoring Airway Disease

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society